current dosage guidelines and ophthalmologic-surveillance techniques , which allow chloroquine to be administered with little risk of retinopathy , should permit an expanded role for this agent in the treatment of the calcium abnormalities of sarcoidosis .
C0008269
chloroquine
C0035309
retinopathy